The significance of this case lies not only in the rarity of the presentation but in the opportunity it provided to establish the primary cancer diagnosis, perform surgical resection of the brain lesion, and initiate personalized systemic treatment guided by immunohistochemistry, including HER2 positivity. This evidence concerns the gene ERBB2 and cancer.